Burkina Faso vs Mozambique: Antiretroviral therapy coverage
Burkina Faso
82.0%
in 2024
Mozambique
82.0%
in 2024
Burkina Faso rank
45th
Mozambique rank
45th
Antiretroviral therapy coverage over time
- Burkina Faso
- Mozambique
How they compare
Burkina Faso currently reports 82.0% against 82.0% in Mozambique, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Mozambique ahead.
Burkina Faso ranks 45th and Mozambique ranks 45th of 143 countries.
Burkina Faso has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Burkina Faso | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.9% | 3.4% | 4.5% | Burkina Faso |
| 2010s | 49.7% | 36.8% | 12.9% | Burkina Faso |
| 2020s | 74.8% | 71.8% | 3.0% | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Burkina Faso or Mozambique?
- Burkina Faso, at 82.0% against 82.0% in Mozambique as of 2024.
- What is the difference in antiretroviral therapy coverage between Burkina Faso and Mozambique?
- 0.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Mozambique?
- 25 years are reported by both, from 2000 to 2024.
- How do Burkina Faso and Mozambique rank globally for antiretroviral therapy coverage?
- Burkina Faso ranks 45th and Mozambique ranks 45th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.